Jodie Pope Morrison's Net Worth
$493 Thousand
Who is Jodie Pope Morrison?
Jodie Pope Morrison does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AILERON THERAPEUTICS INC, Akebia Therapeutics, Inc., Novus Therapeutics, Inc., and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
Jodie Pope Morrison's CIK is 0001618247
Past Insider Trading and Trends
2015 was Jodie Pope Morrison's most active year for acquiring shares with 9 total transactions. Jodie Pope Morrison's most active month to acquire stocks was the month of May. 2015 was Jodie Pope Morrison's most active year for disposing of shares, totalling 12 transactions. Jodie Pope Morrison's most active month to dispose stocks was the month of June. 2016 saw Jodie Pope Morrison paying a total of $32,449.45 for 78,015 shares, this is the most they've acquired in one year. In 2015 Jodie Pope Morrison cashed out on 77,128 shares for a total of $392,366.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AILERON THERAPEUTICS INC (ALRN) Snapshot price: $4.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.50% | 13.7K |
—
|
—
| 58.62K |
Jun 6
| |||
Form 4
|
∞
| 44.92K |
—
|
—
| 44.92K |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Novus Therapeutics, Inc. (ELDN) Snapshot price: $1.755
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +94.80% | 28.02K |
$1.16 | $32,449.45 | 57.57K |
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| +51.15% | 10K |
$7.48 | -$143,755.68 | 29.55K |
Scheduled
|
Jul 28 - Jul 29
| ||
Form 4
| +104.70% | 10K |
$1.06 | $10,624.32 | 19.55K |
Jul 22
| |||
Form 4
|
—
|
0
|
$7.68 | -$194,960.00 | 9.55K |
Scheduled
|
Jun 26 - Jun 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KERYX BIOPHARMACEUTICALS INC No price found
Interim CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -120.00K |
—
|
—
|
0
|
Dec 12
| |||
Form 4
| +9.09% | 10K |
—
|
—
| 120K |
Jun 30
| |||
Form 4
| +1,000.00% | 100K |
—
|
—
| 110K |
May 10
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||